Philip Morris is one step closer to taking over respiratory drugmaker Vectura, as the UK-based company’s board of directors says it will unanimously back the tobacco giant’s $1.5 billion bid.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2025,